微小 RNA 与癌症治疗。
MicroRNAs and cancer therapeutics.
机构信息
State Key Laboratory of Emerging Infectious Diseases, Research Centre of Infection and Immunology, Department of Microbiology Carol Yu Centre for Infection, The University of Hong Kong, Hong Kong, China.
出版信息
Pharm Res. 2011 Dec;28(12):3043-9. doi: 10.1007/s11095-011-0526-2. Epub 2011 Jul 20.
Abstract
MicroRNAs (miRNAs) are small physiological non-coding RNAs that regulate gene expression through an RNA interference (RNAi) mechanism. The expression of miRNAs is tightly controlled both spatially and temporally. Aberrant miRNA expression has been correlated with various cancers. Recent findings suggest that some miRNAs can function as tumor suppressors or oncogenes. In model experiments, the cancer phenotype of some cells can be reverted to normal when the cells are treated with miRNA mimics or inhibitors. Here, we discuss in brief the potential utility of miRNA-based cancer therapy as well as the current limitations thwarting their useful clinical application.
摘要
MicroRNAs (miRNAs) 是小的生理非编码 RNA，通过 RNA 干扰 (RNAi) 机制调节基因表达。miRNAs 的表达在空间和时间上受到严格控制。miRNA 的异常表达与各种癌症有关。最近的研究结果表明，一些 miRNA 可以作为肿瘤抑制因子或癌基因发挥作用。在模型实验中，当用 miRNA 模拟物或抑制剂处理细胞时，一些细胞的癌症表型可以恢复正常。在这里，我们简要讨论了基于 miRNA 的癌症治疗的潜在应用，以及阻碍其临床应用的当前限制。
相似文献
1
MicroRNAs and cancer therapeutics.微小 RNA 与癌症治疗。
Pharm Res. 2011 Dec;28(12):3043-9. doi: 10.1007/s11095-011-0526-2. Epub 2011 Jul 20.
2
MicroRNA-based therapeutics for cancer.基于微小RNA的癌症治疗方法
BioDrugs. 2009;23(1):15-23. doi: 10.2165/00063030-200923010-00002.
3
MicroRNA: Promising Roles in Cancer Therapy.微小 RNA：癌症治疗中的大有可为的角色。
Curr Pharm Biotechnol. 2020;21(12):1186-1203. doi: 10.2174/1389201021666200420101613.
4
microRNA Therapeutics in Cancer - An Emerging Concept.微小 RNA 治疗癌症——一个新兴概念。
EBioMedicine. 2016 Oct;12:34-42. doi: 10.1016/j.ebiom.2016.09.017. Epub 2016 Sep 20.
5
Small non-coding RNAs as novel therapeutics.小非编码 RNA 作为新型治疗药物。
Curr Mol Med. 2010 Jun;10(4):361-8. doi: 10.2174/156652410791317048.
6
microRNAs as oncogenes and tumor suppressors.作为癌基因和肿瘤抑制因子的微小RNA
Dev Biol. 2007 Feb 1;302(1):1-12. doi: 10.1016/j.ydbio.2006.08.028. Epub 2006 Aug 16.
7
Therapeutic microRNA strategies in human cancer.人类癌症的治疗性 microRNA 策略。
AAPS J. 2009 Dec;11(4):747-57. doi: 10.1208/s12248-009-9145-9. Epub 2009 Oct 29.
8
RNA interference and cancer therapy.RNA 干扰与癌症治疗。
Pharm Res. 2011 Dec;28(12):2983-95. doi: 10.1007/s11095-011-0604-5. Epub 2011 Oct 19.
9
Recent trends in targeting miRNAs for cancer therapy.靶向 miRNA 治疗癌症的最新趋势。
J Pharm Pharmacol. 2020 Dec;72(12):1732-1749. doi: 10.1111/jphp.13351. Epub 2020 Aug 12.
10
Deconvoluting the complexity of microRNAs in autophagy to improve potential cancer therapy.解析自噬中微小RNA的复杂性以改善潜在的癌症治疗。
Cell Prolif. 2016 Oct;49(5):541-53. doi: 10.1111/cpr.12277. Epub 2016 Jul 20.
引用本文的文献
1
A critical review on modulators of Multidrug Resistance Protein 1 in cancer cells.关于癌细胞中多药耐药蛋白 1 调节剂的综述评价。
PeerJ. 2022 Jan 5;10:e12594. doi: 10.7717/peerj.12594. eCollection 2022.
2
MicroRNAs in treatment-induced neuroendocrine differentiation in prostate cancer.微小RNA在前列腺癌治疗诱导的神经内分泌分化中的作用
Cancer Drug Resist. 2020;3(4):804-818. doi: 10.20517/cdr.2020.30. Epub 2020 Oct 12.
3
MicroRNA-132 inhibits migration, invasion and epithelial-mesenchymal transition via TGFβ1/Smad2 signaling pathway in human bladder cancer.微小RNA-132通过TGFβ1/Smad2信号通路抑制人膀胱癌的迁移、侵袭和上皮-间质转化。
Onco Targets Ther. 2019 Jul 23;12:5937-5945. doi: 10.2147/OTT.S201731. eCollection 2019.
4
Plant natural modulators in breast cancer prevention: status quo and future perspectives reinforced by predictive, preventive, and personalized medical approach.植物天然调节剂在乳腺癌预防中的应用：预测、预防和个性化医疗方法强化下的现状与未来展望
EPMA J. 2018 Nov 12;9(4):403-419. doi: 10.1007/s13167-018-0154-6. eCollection 2018 Dec.
5
MicroRNA-3619-5p suppresses bladder carcinoma progression by directly targeting β-catenin and CDK2 and activating p21.微小 RNA-3619-5p 通过直接靶向β-连环蛋白和 CDK2 并激活 p21 抑制膀胱癌进展。
Cell Death Dis. 2018 Sep 20;9(10):960. doi: 10.1038/s41419-018-0986-y.
6
The role of the mediators of inflammation in cancer development.炎症介质在癌症发展中的作用。
Pathol Oncol Res. 2015 Jul;21(3):527-34. doi: 10.1007/s12253-015-9913-z. Epub 2015 Mar 5.
7
miRNA-based therapies: strategies and delivery platforms for oligonucleotide and non-oligonucleotide agents.基于微小RNA的疗法：寡核苷酸和非寡核苷酸药物的策略与递送平台
Future Med Chem. 2014;6(17):1967-84. doi: 10.4155/fmc.14.116.
8
Breast- and salivary gland-derived adenoid cystic carcinomas: potential post-transcriptional divergencies. A pilot study based on miRNA expression profiling of four cases and review of the potential relevance of the findings.乳腺和唾液腺来源的腺样囊性癌：潜在的转录后差异。一项基于4例病例的miRNA表达谱分析及对研究结果潜在相关性综述的初步研究。
Pathol Oncol Res. 2015 Jan;21(1):29-44. doi: 10.1007/s12253-014-9770-1. Epub 2014 Sep 21.
9
Oligonucleotide conjugates for therapeutic applications.用于治疗应用的寡核苷酸缀合物。
Ther Deliv. 2013 Jul;4(7):791-809. doi: 10.4155/tde.13.47.
10
MicroRNA-21 gene and cancer.miRNA-21 基因与癌症。
Med Oncol. 2013 Mar;30(1):376. doi: 10.1007/s12032-012-0376-8. Epub 2013 Jan 1.
本文引用的文献
1
miR-130b Promotes CD133(+) liver tumor-initiating cell growth and self-renewal via tumor protein 53-induced nuclear protein 1.miR-130b 通过肿瘤抑制蛋白 53 诱导核蛋白 1 促进 CD133(+)肝肿瘤起始细胞的生长和自我更新。
Cell Stem Cell. 2010 Dec 3;7(6):694-707. doi: 10.1016/j.stem.2010.11.010.
2
hsa-miR-191 is a candidate oncogene target for hepatocellular carcinoma therapy.hsa-miR-191 是肝细胞癌治疗的候选癌基因靶点。
Cancer Res. 2010 Oct 15;70(20):8077-87. doi: 10.1158/0008-5472.CAN-10-1313. Epub 2010 Oct 5.
3
MicroRNA-132-mediated loss of p120RasGAP activates the endothelium to facilitate pathological angiogenesis.MicroRNA-132 介导的 p120RasGAP 丧失激活内皮细胞，促进病理性血管生成。
Nat Med. 2010 Aug;16(8):909-14. doi: 10.1038/nm.2186. Epub 2010 Aug 1.
4
Expanding the microRNA targeting code: functional sites with centered pairing.扩展 microRNA 靶向代码：具有中心配对的功能位点。
Mol Cell. 2010 Jun 25;38(6):789-802. doi: 10.1016/j.molcel.2010.06.005.
5
Nanoparticles modified with tumor-targeting scFv deliver siRNA and miRNA for cancer therapy.经肿瘤靶向 scFv 修饰的纳米颗粒可递送 siRNA 和 miRNA 用于癌症治疗。
Mol Ther. 2010 Sep;18(9):1650-6. doi: 10.1038/mt.2010.136. Epub 2010 Jul 6.
6
Regulation of mRNA translation and stability by microRNAs.miRNAs 对 mRNA 翻译和稳定性的调控。
Annu Rev Biochem. 2010;79:351-79. doi: 10.1146/annurev-biochem-060308-103103.
7
Identification of small molecules that suppress microRNA function and reverse tumorigenesis.鉴定抑制 microRNA 功能并逆转肿瘤发生的小分子。
J Biol Chem. 2010 Aug 6;285(32):24707-16. doi: 10.1074/jbc.M109.062976. Epub 2010 Jun 7.
8
Genetic variation in microRNA networks: the implications for cancer research.miRNA 网络中的遗传变异：对癌症研究的影响。
Nat Rev Cancer. 2010 Jun;10(6):389-402. doi: 10.1038/nrc2867.
9
Therapeutic silencing of miR-10b inhibits metastasis in a mouse mammary tumor model.miR-10b 的治疗性沉默抑制小鼠乳腺肿瘤模型中的转移。
Nat Biotechnol. 2010 Apr;28(4):341-7. doi: 10.1038/nbt.1618. Epub 2010 Mar 28.
10
Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection.慢性丙型肝炎病毒感染灵长类动物中 microRNA-122 的治疗性沉默。
Science. 2010 Jan 8;327(5962):198-201. doi: 10.1126/science.1178178. Epub 2009 Dec 3.
Zotero 插件